loader

World Tenders & Procurement Opportunities

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

World Biggest Tenders Source

This tender with title Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens. has been published on Bidding Source portal dated 18 Oct 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4) genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Contract notice
2019/S 201-487852
Germany
Germany-Hanover
18 Oct 2019
31 Dec 2021
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

675355- Germany – Pharmaceutical products – Open house drug discount contracts Risankizumab, ATC L04AC18 Germany 674661- Germany – Pharmaceutical products – Open house drug discount agreements Allergen extracts from grass pollen for sublingual application, trade name Oralair(R), ATC V01AA02 Germany 673779- Germany – Pharmaceutical products – Open house drug discount contracts Pegfilgrastim, ATC L03AA13 Germany 673381- Germany – Pharmaceutical products – Open house drug discount contracts Natalizumab in the dosage form concentrate for preparation of an infusion solution, ATC L04AG03 Germany 674023- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a, Paragraph 8 of the Social Code Book V (Open House Model) Germany 674957-Awarded - Germany – Pharmaceutical products – 1/DLII6/PM020 - Arzneimittel - Virostatika Germany 660388- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient flecainide (WHO ATC code: C01BC04) Germany 657850- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient leuprorelin (ATC code according to WHO: L02AE02) Germany 663605- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient bimatoprost (ATC code: S01EE03). Germany 666838- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient teriparatide (ATC code: H05AA02). Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans